Teva Pharmaceutical Industries Ltd. – Teva Expands European biosimilars portfolio with launch of AHZANTIVE® (aflibercept) biosimilar to Eylea®
Teva Expands European biosimilars portfolio with launch of AHZANTIVE® (aflibercept) biosimilar to Eylea®
AHZANTIVE® (aflibercept) is an EMA-approved biosimilar to Eylea®…